SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001802768-24-000012
Filing Date
2024-02-15
Accepted
2024-02-15 09:05:28
Documents
89
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rprx-20231231.htm   iXBRL 10-K 2543160
2 EX-4.2 rprx-20231231ex42.htm EX-4.2 40754
3 EX-10.21 rprx-20231231ex1021.htm EX-10.21 1316748
4 EX-21.1 rprx-20231231ex211.htm EX-21.1 7459
5 EX-23.1 rprx-20231231ex231.htm EX-23.1 3750
6 EX-31.1 rprx-20231231ex311.htm EX-31.1 9220
7 EX-31.2 rprx-20231231ex312.htm EX-31.2 9285
8 EX-32 rprx-20231231ex32.htm EX-32 5102
9 EX-97.1 rprx-20231231ex971.htm EX-97.1 42171
15 rprx-20231231_g1.jpg GRAPHIC 95209
16 rprx-20231231_g2.jpg GRAPHIC 62007
17 rprx-20231231_g3.jpg GRAPHIC 74768
18 rprx-20231231_g4.jpg GRAPHIC 139379
  Complete submission text file 0001802768-24-000012.txt   13589237

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rprx-20231231.xsd EX-101.SCH 72278
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rprx-20231231_cal.xml EX-101.CAL 101744
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rprx-20231231_def.xml EX-101.DEF 408429
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rprx-20231231_lab.xml EX-101.LAB 875433
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rprx-20231231_pre.xml EX-101.PRE 577248
91 EXTRACTED XBRL INSTANCE DOCUMENT rprx-20231231_htm.xml XML 1694611
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39329 | Film No.: 24642367
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)